Newsroom
Company news, product launches and press coverage from EClinCloud.
EClinCloud Named to the Top 5 Most Investable Companies in the Digital EconomyResults of the 12th "Search for Ningbo's Most Investable Companies" selection have been announced: EClinCloud stood out among more than 620 participating companies to enter the Top 5 in the "Digital Economy" category, while founder and CEO Dr. Qin Long received the "Entrepreneurial Pioneer" individual award.
Farewell to Keigo Higashino: Revisiting Colorectal Cancer and Common Clinical Assessment ToolsRenowned Japanese author Keigo Higashino passed away from colorectal cancer on the 23rd local time at the age of 68. As one of Asia's most influential writers, Higashino wrote numerous classics including "Journey Under the Midnight Sun," "The Devotion of Suspect X," and "The Miracles of the Namiya General Store," which have been translated into dozens of languages, accompanying countless readers and shaping a generation's reading memories. As news of his passing spread, countless readers mourning the master of mystery fiction also seriously asked for the first time: what exactly is colorectal cancer? Keigo Higashino (File photo) 1 What is colorectal cancer? Colorectal cancer (colorectal canc
Warm Congratulations to EClinCloud Partner Trinomab on Its Successful Listing on the STAR MarketCongratulations! On July 21, 2026, Zhuhai Trinomab Pharmaceutical Co., Ltd. (stock abbreviation: Trinomab; stock code: 688806) was officially listed on the Shanghai Stock Exchange STAR Market, entering a new stage of capitalization and high-quality development. As a long-term partner of Trinomab, EClinCloud extends its warm congratulations on Trinomab's successful listing on the STAR Market. The two parties have long conducted in-depth collaboration on clinical research for innovative drugs. EClinCloud has consistently provided Trinomab with integrated solutions including eCOA and end-to-end service support, helping the research team achieve high-quality clinical data collection and
Dragon Boat Festival | Fragrant Zongzi Leaves, Wishing You Health and Peace!About EClinCloud: EClinCloud is a leading AI company in the clinical research industry, building an AI-driven integrated intelligent clinical cloud platform and endpoint assessment technologies. It provides global pharmaceutical companies and research institutions with technology products such as eCOA, CTMS, eTMF, EDC, RTSM, IRC, and RM, alongside scale management, linguistic validation, rater training, and data quality analysis services to create efficient, precise digital solutions. Relying on AI prediction models and an intelligent data platform, it dynamically assesses and helps improve the success rate of drug clinical trials, helping shorten drug/device R&D cycles to benefit patients.